Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 12, Supplement 1, 2001   [Index by Author] 


Down Introduction
Down Symposium Article


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Introduction Back

M. Piccart
Introduction
Ann Oncol 2001 12: S1; doi:10.1093/annonc/12.suppl_1.S1 [PDF] [Request Permissions]  

Symposium Article Back

I. Rubin and Y. Yarden
The Basic Biology of HER2
Ann Oncol 2001 12: S3-S8; doi:10.1093/annonc/12.suppl_1.S3 [Abstract] [PDF] [Request Permissions]  

R. M. Neve, H. A. Lane, and N. E. Hynes
The Role of Overexpressed HER2 in Transformation
Ann Oncol 2001 12: S9-S13; doi:10.1093/annonc/12.suppl_1.S9 [Abstract] [PDF] [Request Permissions]  

S. Ménard, P. Casalini, M. Campiglio, S. Pupa, R. Agresti, and E. Tagliabue
HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer
Ann Oncol 2001 12: S15-S19; doi:10.1093/annonc/12.suppl_1.S15 [Abstract] [PDF] [Request Permissions]  

H. A. Lane, A. B. Motoyama, I. Beuvink, and N. E. Hynes
Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling
Ann Oncol 2001 12: S21-S22; doi:10.1093/annonc/12.suppl_1.S21 [Abstract] [PDF] [Request Permissions]  

T. Cooke, J. Reeves, A. Lanigan, and P. Stanton
HER2 as a prognostic and predictive marker for breast cancer
Ann Oncol 2001 12: S23-S28; doi:10.1093/annonc/12.suppl_1.S23 [Abstract] [PDF] [Request Permissions]  

P. Valagussa
HER2 Status: A Statistician's View
Ann Oncol 2001 12: S29-S34; doi:10.1093/annonc/12.suppl_1.S29 [Abstract] [PDF] [Request Permissions]  

J. Baselga and J. Albanell
Mechanism of action of anti-HER2 monoclonal antibodies
Ann Oncol 2001 12: S35-S41; doi:10.1093/annonc/12.suppl_1.S35 [Abstract] [PDF] [Request Permissions]  

B. Leyland-Jones, A. Arnold, K. Gelmon, S. Verma, J.-P. Ayoub, A. Seidman, R. Dias, J. Howell, and A. Rakhit
Pharmacologic insights into the future of trastuzumab
Ann Oncol 2001 12: S43-S47; doi:10.1093/annonc/12.suppl_1.S43 [Abstract] [PDF] [Request Permissions]  

J. Baselga
Phase I and II clinical trials of trastuzumab
Ann Oncol 2001 12: S49-S55; doi:10.1093/annonc/12.suppl_1.S49 [Abstract] [PDF] [Request Permissions]  

W. Eiermann and on behalf of the International Herceptin Study Group
Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data
Ann Oncol 2001 12: S57-S62; doi:10.1093/annonc/12.suppl_1.S57 [Abstract] [PDF] [Request Permissions]  

L. Gianni
Tolerability in patients receiving trastuzumab with or without chemotherapy
Ann Oncol 2001 12: S63-S68; doi:10.1093/annonc/12.suppl_1.S63 [Abstract] [PDF] [Request Permissions]  

R. Bell
Ongoing trials with trastuzumab in metastatic breast cancer
Ann Oncol 2001 12: S69-S73; doi:10.1093/annonc/12.suppl_1.S69 [Abstract] [PDF] [Request Permissions]  

I. Smith
Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab
Ann Oncol 2001 12: S75-S79; doi:10.1093/annonc/12.suppl_1.S75 [Abstract] [PDF] [Request Permissions]  

S. Scholl, P. Beuzeboc, and P. Pouillart
Targeting HER2 in other tumor types
Ann Oncol 2001 12: S81-S87; doi:10.1093/annonc/12.suppl_1.S81 [Abstract] [PDF] [Request Permissions]  

M. J. Piccart
Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe
Ann Oncol 2001 12: S89-S94; doi:10.1093/annonc/12.suppl_1.S89 [Abstract] [PDF] [Request Permissions]  

M. Mrsic, M. Grgic, Z. Budisic, P. Podolski, V. Bogdanic, B. Labar, J. Jakic-Razumovic, N. Restek-Samarzija, and M. Gosev
Trastuzumab in the treatment of advanced breast cancer: Single-center experience
Ann Oncol 2001 12: S95-S96; doi:10.1093/annonc/12.suppl_1.S95 [Abstract] [PDF] [Request Permissions]  

G. Schaller, K. Evers, S. Papadopoulos, A. Ebert, and H. Bühler
Current use of HER2 tests
Ann Oncol 2001 12: S97-S100; doi:10.1093/annonc/12.suppl_1.S97 [Abstract] [PDF] [Request Permissions]  

A. Thor
HER2 – a discussion of testing approaches in the USA
Ann Oncol 2001 12: S101-S107; doi:10.1093/annonc/12.suppl_1.S101 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.